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Phospholipase Cg2 Is Essential in the Functions
of B Cell and Several Fc Receptors
Reth and Wienands, 1997). Major goals of signal trans-
duction studies have been to identify the substrates of
these activated kinases and to assess their role in the
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Memphis, Tennessee 38063 Cantley, 1997). The importance of this pathway has been
emphasized by the derivation of mice lacking the p85a
gene (Fruman et al., 1999; Suzuki et al., 1999). Among
Summary the defects that exist is a disruption of signaling through
the B cell receptor, resulting in a phenotype that is simi-
Many receptors activate phospholipase Cg1 or -g2. To
lar to that seen in mice lacking the tyrosine kinase Btk
assess the role of PLCg2, we derived enzyme-deficient
(Kerner et al., 1995; Khan et al., 1995).mice. The mice are viable but have decreased mature
Phosphatidylinositols are hydrolyzed by phospholi-B cells, a block in pro-B cell differentiation, and B1 B
pases to generate diacyl-glycerol and inositol phos-cell deficiency. IgM receptor±induced Ca21 flux and
phates including inositol 1,4,5-trisphosphate (IP3) (Rheeproliferation to B cell mitogens are absent. IgM, IgG2a,
and Bae, 1997). The diacyl-glycerol generated activatesand IgG3 levels are reduced, and T cell±independent
protein kinase C (PKC) family members, while IP3 medi-antibody production is absent. The similarity to Btk-
ates the mobilization of Ca21 from internal stores, re-or Blnk-deficient mice demonstrates that PLCg2 is
sulting in a transient intracellular Ca21 flux. Mammaliandownstream in Btk/Blnk signaling. FcRg signaling is
cells contain at least ten genes that encode phosphati-also defective, resulting in a loss of collagen-induced
dylinositol 4,5-bisphosphate±specific phospholipase Cplatelet aggregation, mast cell FceR function, and NK
isozymes (Rhee and Bae, 1997). The PLC-b subfamilycell FcgRIII and 2B4 function. The results define a
of enzymes (b1±4) are stringently regulated by G protein±signal transduction pathway broadly utilized by immu-
coupled receptors, while the PLC-d isoforms (1±4) arenoglobulin superfamily receptors.
regulated by largely unknown mechanisms, although
Ca21 may be involved. The two PLCg isoforms g1 and
g2 are unique in containing two SH2 domains, an SH3Introduction
domain, and a PH domain. The SH2 domains allow their
recruitment to activated receptor complexes throughHematopoiesis is regulated through the concerted ac-
tion of a variety of cytokine receptors and members of specific sites of tyrosine phosphorylation on receptor
the immunoglobulin superfamily of receptors. Engage- chains. The PH domain is speculated to be important
ment of any of these receptor systems induces the acti- in docking the enzyme to the inner membrane by bind-
vation of receptor-associated tyrosine kinases and sub- ing PIP3. The activities of PLCg1 and -g2 are thought
sequent induction of the tyrosine phosphorylation of a to be regulated through direct tyrosine phosphorylation
variety of substrates, including the components of the (Nishibe et al., 1990), SH2-mediated conformational
receptor. The functions of the cytokine receptor super- changes of the enzyme, or by physical recruitment to
family are critically dependent upon the Jak family of the membrane-localized receptor complex.
cytoplasmic protein tyrosine kinases (Ihle, 1995; Ihle and A wide variety of cytokines, tyrosine kinase receptors,
Kerr, 1995; O'Shea, 1997). In contrast, the T cell and B and immunoglobulin superfamily receptors (TCR, BCR,
cell antigen receptors as well as the complexes associ- and Fc receptors) induce the tyrosine phosphorylation of
ated with signaling through Fc receptors are dependent PLCg1 and/or PLCg2. In particular, erythropoietin (Epo)
upon members of the Src family of kinases, the Tec induces the tyrosine phosphorylation of both isoforms
family of kinases, and the Zap70/Syk kinases (Paul and (Miura et al., 1994; unpublished data). Induction requires
Seder, 1994; Weiss and Littman, 1994; Daeron, 1997; the distal region of the Epo receptor containing tyrosine
residues that are required for recruitment to the receptor
complex. In addition, we have found that both PLCg1
7 To whom correspondence should be addressed (e-mail james.ihle@
and PLCg2 bind to a major site of tyrosine phosphory-stjude.org).
lation within the kinase domain of Jak2 (unpublished8 Present address: Laboratory of Molecular and Cellular Neurosci-
ence, Rockefeller University, New York, New York. data), the tyrosine kinase associated with the Epo recep-
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tor complex. The significance of PLCg1- and PLCg2-
induced tyrosine phosphorylation in Epo responses is
unclear, since Epo receptor truncation mutants that no
longer support their tyrosine phosphorylation function
normally.
The potential physiological role of PLCg1 has been
approached by the derivation of mice that lack the en-
zyme (Ji et al., 1997a). Disruption of the PLCg1 gene
resulted in embryonic lethality during early to midgesta-
tion, with death occurring at approximately embryonic
day 9. Using fibroblasts derived from these embryos, it
was shown that epidermal growth factor (EGF) receptor
activation and internalization were normal (Ji et al.,
1997b). Moreover, growth factor±induced DNA synthe-
sis, cell growth and the ability of the cells to migrate were
unaffected. However, the PLCg1-deficient cells failed to
mobilize intracellular Ca21 in response to EGF.
To assess the potential contribution of PLCg2 to sig-
naling through the hematopoietic receptors, we have
derived mice that are deficient in the enzyme. Unlike
PLCg1, disruption of the PLCg2 gene does not lead to
an embryonic lethality. However, the PLCg2-deficient
mice have a number of defects in signaling through
immunoglobulin receptor superfamily receptors. In B
cells, the response to engagement of the IgM antigen
Figure 1. Targeted Disruption of the PLCg2 Gene in Micereceptor is defective, resulting in a phenotype that is
(A) A targeting construct was developed that would remove thevery similar to that seen in Btk-deficient mice. In addi-
second coding exon and flanking sequences as indicated. The loca-
tion, collagen-induced platelet aggregation is defective, tions of the 59 and 39 external probes and PCR primers for genotyp-
demonstrating a critical role for PLCg2 in signaling ing are indicated. The following restriction enzyme sites are shown:
B, BamHI; E, EcoRI; X, XbaI.through a receptor requiring the FcRg chain. The pheno-
(B) Southern blot analysis of XbaI-digested genomic DNA fromtype of the PLCg2-deficient mice, along with the pheno-
PLCg2 heterozygous F1 mice probed with the indicated externaltypes of several other gene deletions, supports the con-
probe. The wild-type allele is 6.4 kb and the mutant allele is 12 kb.
cept that a conserved signaling cassette involving (C) Immunoprecipitation and Western blot analysis of PLCg2 and
several gene products is required for the function of PLCg1 protein expression in spleen extracts from PLCg21/1,
many members of the immunoglobulin receptor super- PLCg21/2, and PLCg22/2 mice.
family.
Hematopoiesis Is Not Overtly Affected
by PLCg2 Deficiency
Results PLCg2 is primarily expressed in hematopoietic cell lin-
eages and has been implicated in the signaling by sev-
Generation of PLCg2-Deficient Mice eral cytokines and in B cells (Sultzman et al., 1991; Cog-
geshall et al., 1992; Hempel et al., 1992; Rothe et al.,The PLCg2 gene was disrupted in murine ES cells by
1993; Takata et al., 1995; Takata and Kurosaki, 1996;the replacement of a 3.8 kb fragment containing the
Bourette et al., 1997). We therefore examined a numbersecond coding exon with a neo gene expression cas-
of hematopoietic functions in the mutant mice. Theresette (Figure 1A). Eight ES clones were obtained con-
were no significant effects on several parameters includ-taining the appropriately targeted disrupted allele and
ing the number of red cells, hemoglobin levels, or hema-injected into C57BL/6 blastocysts. Germline transmis-
tocrits. There was a slight increase in the numbers ofsion was obtained from two independent ES cell clones,
circulating neutrophils and macrophages (data notand both mouse lines had comparable phenotypes.
shown). The recovery of bone marrow cells was normal,Southern blot analysis confirmed the presence of the
and in colony assays of bone marrow progenitors (Tabledisrupted locus (Figure 1B). Heterozygous mice were
1), there were no detectable alterations in the numberphenotypically normal and were bred to obtain mice
of erythroid (CFU-E) or megakaryocyte (CFU-Meg) pro-
homozygous for the mutated allele. Homozygous mice genitors. There were also no differences in the frequency
were viable and were examined for PLCg2 protein by of colonies in response to IL-3, IL-5, GM-CSF, G-CSF,
immunoprecipitation and Western blotting of splenic ex- or SCF. PLCg2-deficient bone marrow cells responded
tracts with an antiserum to a carboxy-terminal-derived normally to CSF-1 (Table 1), and the colonies contained
peptide. As illustrated in Figure 1C, homozygous PLCg2 morphologically normal macrophages (data not shown).
mutant mice had no detectable protein immunoreactive Similarly, peripheral blood monocyte/macrophages
with the carboxy-terminal-specific antibody at the posi- were normal in PLCg2-deficient mice (data not shown),
tion of PLCg2 or with lower molecular weight sizes (data although previous studies indicated that activation of
not shown). In addition, the absence of PLCg2 protein PLCg2 was necessary for macrophage differentiation
(Bourette et al., 1997).did not detectably affect the expression of PLCg1.
Roles of PLCg2
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Table 1. In Vitro Colony Formation by Bone Marrow Hematopoietic Progenitors from Wild-Type and PLCg2-Deficient Mice in Response
to Various Cytokines
Cytokine Epo IL-3 IL-5 IL-7 Tpo G-CSF GM-CSF CSF-1 SCF
Colony Type CFU-E CFU-Mix CFU-Eos Pre-B CFU-Meg CFU-G CFU-GM CFU-M CFU-Mix
Wild Type 505 6 49 40 6 4 23 6 2 44 6 7 14 6 2 23 6 2 45 6 2 302 6 56 89 6 4
PLCg2 Deficient 535 6 21 36 6 6 15 6 2 413 6 17 17 6 7 16 6 5 48 6 5 300 6 29 90 6 4
Means 6 standard deviation of number of colonies 105 nucleated bone marrow cells (n 5 5).
B Cell Population in Wild-Type and PLCg2-Deficient Mice (in Millions)
Bone Marrow (n 5 8)
B Lineage Cells Pro-B cells Pre-B Cells IgM1B220int IgM1B220hi
(B2201) (CD431B2201) (Fraction D) (Fraction E) (Fraction F)Total Cells
Number Percent Number Percent Number Percent Number Percent Number Percent
Wild Type 80.5 6 16 19.2 6 4.9 23.9 6 4.5 2.1 6 0.5 2.6 6 0.4 6.9 6 2.2 9.0 6 2.1 3.3 6 1.2 4.0 6 1.2 3.7 6 1.3 4.5 6 1.0
PLCg2 Deficient 76.4 6 15.6 12.1 6 2.1 16.2 6 2.6 1.7 6 0.3 2.2 6 0.1 3.6 6 1.1 4.8 6 1.5 1.7 6 0.5 2.2 6 0.6 0.6 6 0.2 0.8 6 0.2
Spleen (n 5 9) Lymph nodes (n 5 8)
B Lineage Cells B Lineage Cells
(B2201) (B2201)Total cells Total Cells
Number Percent Number Percent
Wild Type 62.6 6 9.8 32.7 6 4.2 52.7 6 6.9 4.8 6 1.1 2.0 6 0.7 42.3 6 10.1
PLCg2 Deficient 82.1 6 17.9 24.5 6 5.7 30.9 6 8.4 2.4 6 0.8 0.3 6 0.1 11.7 6 1.2
The phenotype of lymphocyte was determined by flow cytometry. The numbers and percentages of each group of cells were determined for
each mouse, and the mean value and standard deviation were calculated.
Defective B Cell Functions in PLCg2-Deficient Mice in response to the combination of anti-IgM and IL-4 at
any of the time points examined (1, 2, 3, or 4 days),In contrast to the other hematopoietic parameters, there
was a consistent 10-fold increase in the frequency of including the time illustrated in Figure 2E. Moreover,
increasing the concentration of anti-IgM did not resultbone marrow±derived, IL-7-responsive B cell colonies
(Table 1). FACS analysis of bone marrow cells (Figure in a detectable response (data not shown). There was
also a marked decrease in the response to anti-CD40.2A) indicated a shift of the B cell populations to a more
immature population of B2201IgM2 and a decrease in In contrast, the response to LPS was only partially re-
duced, while the response to phorbol ester and iono-the more mature B220highIgM1 population, consistent
with the increase in IL-7-responsive cells. Although the mycin was not significantly different than that of cells
from wild-type mice. Cross-linking of the B cell receptorsrecovery of bone marrow cells was comparable between
control and mutant mice, there was approximately a by anti-IgM induces an increase in intracellular Ca21 and
this has been suggested to require PLCg2 (Hempel et30% decrease in B2201 B cells recovered (Table 1).
Although percentage of the pro-B cells (CD431B2201) al., 1992; Scharenberg and Kinet, 1998). Consistent with
this hypothesis, anti-IgM stimulation of PLCg2-deficientwas comparable in wild-type and PLCg2-deficient bone
marrow, the ratio of pro-B cells to pre-B cells was in- B cells failed to induce an increase in intracellular Ca21
(Figure 3B), whereas the response to inomycin was nor-creased in PLCg2-deficient bone marrow. In addition,
population of pre-B, IgM1B220int (fraction E), and mal (data not shown). To determine whether PLCg2
function follows the activation and recruitment of BtkIgM1B220hi (fraction F) cells were decreased in PLCg2-
deficient mice (Table 1). In preparations of splenic lym- and Blnk, the consequences of PLCg2 deficiency on
their induced phosphorylation were examined. As dem-phocytes (n 5 9), the percentage of B2201 cells was
reduced from 52.7% 6 6.9% to 30.9% 6 8.4% (Table onstrated in Figure 3A, anti-IgM induced a comparable
level of tyrosine phosphorylation of Btk and Blnk in both1). As shown in Figure 2B, there was a marked decrease
in the IgMlowIgDhigh population and in the most mature, control and PLCg2-deficient cells. Together, these data
demonstrate that PLCg2 is an essential, nonredundantB2201IgM2 population (Figure 2C). In lymph nodes there
was a 50% reduction in total cell numbers and the per- component of IgM-mediated signaling in B cells down-
stream from Btk activation and Blnk phosphorylation.centage of B cells was reduced from 42.3% 6 10.1%
to 11.7% 6 1.2% (Table 1). Last, there was a complete To assess the consequences of the altered B cell
functions on the immune system, normal serum immu-absence of CD51 B cells in peritoneal lymphocytes (Fig-
ure 2D). Collectively, the phenotypic changes in the B noglobulin levels and the abilities to produce antibodies
to T-dependent and T-independent antigens were ex-cell populations are very similar to those observed in
Btk- and in Blnk-deficient mice (Kerner et al., 1995; Khan amined. As illustrated in Figure 4A, nonmanipulated
PLCg2-deficient mice had significantly lower levels ofet al., 1995).
The abilities of splenic B cells to respond to various IgM, IgG2a, and IgG3, while the concentrations of IgA,
IgG1, and IgG2b were within normal ranges. When im-stimuli are illustrated in Figure 2E. There was a marked
inability to proliferate in response to anti-IgM alone or munized with the T-independent antigen nitrophenyl±
Immunity
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Figure 2. Flow Cytometric and Functional Analysis of PLCg2-Deficient B Cells
(A) Bone marrow cells from 5- to 6-week-old wild-type and PLCg2-deficient mice were stained with Cy-chrome-conjugated anti-B220 and
FITC-conjugated anti-IgM.
(B and C) Spleen cells from wild-type and PLCg2-deficient mice were stained with PE-conjugated anti-IgM, FITC-conjugated anti-IgD, and
Cy-chrome-conjugated anti-B220.
(D) Cells from the peritoneal cavity of wild-type and PLCg2-deficient mice were stained with PE-conjugated anti-CD5 and FITC-conjugated
anti-IgM.
(E) Purified splenic B cells from wild-type and PLCg2-deficient mice were cultured with the indicated stimuli.
conjugated Ficoll (NP-Ficoll), individual wild-type mice mice. Analysis of a large number of offspring demon-
strated that embryos of days12±19 (n 5 109) were pres-produce various antibody isotypes against NP (Figure
4B). However, individual PLCg2-deficient mice failed to ent at the expected frequencies, but at weaning, the
homozygous mice were being obtained at approxi-respond with the production of any of the antibody iso-
types. In contrast, the response to the T-dependent anti- mately two-thirds the expected frequency (n 5 458). In
examining embryos between day 12 and 19, subcutane-gen ovalbumin was normal, with the exception of an
ous hemorrhaging was often seen as illustrated by oneincreased production of IgM (Figure 4C). Collectively,
example shown in Figure 5A. Examination of adult micethese phenotypes are similar to those observed in Btk-
also identified intraperitoneal hemorrhaging (data notand Blnk-deficient mice (Kerner et al., 1995; Khan et al.,
shown) and gastrointestinal hemorrhaging (Figure 5B).1995).
This was also evident in histological sections of theIn contrast to the B cell defects, T cell differentiation
intestines (Figure 5C). Thus, in the absence of PLCg2,was unaffected based on the presence of comparable
there is a bleeding disorder that may account for thepercentages of CD4- and CD8-positive lymphocytes in
perinatal lethality as well as contributing to the smallerthymus or spleen. In addition, the ability of PLCg2-defi-
size of some of the PLCg2-deficient mice.cient T cells to respond to various stimuli, including anti-
Since platelet counts and the morphology of the plate-CD3, anti-CD3 in combination with anti-CD28, or limiting
lets were normal, platelet function was examined. Asanti-CD3 with increasing concentrations of IL-2, were
illustrated in Figure 5F, the ability of platelets to aggre-not detectably different from T cells of wild-type mice
gate in response to collagen was absent in PLCg2-defi-(data not shown).
cient mice. Conversely, the response to thrombin or
ADP was unaffected. One of the consequences of en-
gagement of the collagen receptor is the release of ATP/Platelet Dysfunction in PLCg2-Deficient Mice
Although viable PLCg2-deficient mice were obtained, it ADP and thromboxinA2 (TXA2), which, in turn, mediate




PLCg2 deficiency results in a very defined set of pheno-
types supporting the hypothesis that this enzyme func-
tions, nonredundantly, to mediate the effects of several
immunoglobulin superfamily receptors. The spectrum
of defects within B cell development and function are
remarkably similar to those previously described for Btk-
deficient mice (Kerner et al., 1995; Khan et al., 1995)
or in xid mutant mice containing a naturally occurring
mutation of Btk (Rawlings et al., 1993; Thomas et al.,
1993). These similarities include an in vivo shift to more
immature B cells, the marked absence of CD51 B cells,
the selective reduction in specific classes of immuno-
globulins, and the loss of the ability to respond to
T-independent antigens while retaining the ability to re-
spond to T-dependent antigens. At the cellular level, the
absence of PLCg2 affects the ability of B cells to respond
to stimulation through the immunoglobulin receptor
complex in a manner similar to that observed in Btk-
deficient or xid B cells or Blnk-deficient cells.
In humans, mutations in Btk result in a much more
severe effect on B cell development and function caus-
Figure 3. Activation of BTK and BLNK and Induction of [Ca21]i in ing a life-threating hypogammaglobulinemia (Tsukada
Wild-Type and PLCg2-Deficient B Cells in Response to Anti-IgM et al., 1993; Vetrie et al., 1993). The basis for the differ-
(A) Splenic B cells were not stimulated (minus) or were stimulated ences in the phenotypes of Btk-deficient humans versus
with anti-IgM (aIgM) for 3 min. The cells were collected and analyzed mice is not known but may involve a redundancy in proteinfor the induction of tyrosine phosphorylation of BTK and BLNK.
kinases in mice that does not occur in humans. Never-(B) Induction of [Ca21]i was measured by flow cytometry following
theless, it raises the question of whether agammaglobu-stimulation of Indo-1-labeled splenic B cells with anti-IgM. The lines
of the plot were drawn at levels of constant cell number. linemias exist in humans that result from mutations in
PLCg2. In contrast to Btk, however, the phenotype of
PLCg2-deficient mice would predict the possible pres-
ence of other deficiencies including platelet function.(Offermanns et al., 1997). As illustrated in Figures 5D
In addition to Btk, other genes have been implicatedand 5E, PLCg2-deficient platelets did not release TXA2
in signaling through the IgM antigen receptor to induce(measured as 11-dehydro TXB2) or ATP following colla-
a Ca21 flux. Both Lyn and Syk have been implicated in thegen stimulation. The results are consistent with the hy-
regulation of B cell receptor±coupled Ca21 mobilizationpothesis that PLCg2 is critical in signaling through colla-
(Takata et al., 1994). However, the deletion of Lyn resultsgen receptors that require the FcRg chain for signaling.
in a complex phenotype that is most consistent with anThe requirement of PLCg2 for signaling through the
essential role in negative regulation of B cell proliferationFcRg-containing collagen receptor on platelets sug-
(Chan et al., 1997). Signaling through the pre-BCR com-gested the possibility that other Fc receptors might simi-
plex is also dependent upon the presence of Syk (Chenglarly require PLCg2. We therefore examined FceR func-
et al., 1995). More recently, the adaptor protein Blnk,tion in the degranulation of mast cells. Mast cells were
also termed SLP-65, has been shown to be required for
obtained from long-term cultures of bone marrow from
coupling Syk activation to the activation of PLCg2 (Ishiai
wild-type and PLCg2-deficient animals. The cells were
et al., 1999). Thus, the activation of a Ca21 flux is envi-
labeled with [3H]serotonin, sensitized with monoclonal sioned to require the assembly of a B cell receptor com-
mouse IgE, and then triggered with a monoclonal anti- plex consisting of a Src kinase (Lyn), a Zap70/Syk kinase
mouse IgE antibody. As illustrated in Figure 6A, degranu- (Syk), and a Tec family kinase (Btk) and the adaptor
lation, as measured by the release of [3H]serotonin, was protein Blnk (SLP-65). This complex is hypothesized to
reduced in PLCg2-deficient mast cells. However, IgE be essential for the recruitment and activation of PLCg2.
cross-linking induced a comparable level of IL-4 produc- Mice lacking the p85a gene are also defective in B
tion (Figure 6B). FcgRIII is required for antibody-depen- cell signaling and in vivo B cell differentiation in a manner
dent cell cytotoxicity (ADCC) of NK cells. To assess the that is similar to, although less severe, than that seen
role of PLCg2 in this function, the ability of NK cells in Btk-, Blnk-, and PLCg2-deficient mice (Kerner et al.,
to lyse P815 cells coated with an IgG2b monoclonal 1995; Khan et al., 1995; Fruman et al., 1999; Jumaa et
antibody to FcgRII/III was examined. As illustrated in al., 1999; Pappu et al., 1999; Suzuki et al., 1999). Since
Figure 6C, this NK function was reduced with PLCg2- both Btk and PLCg2 contain pleckstrin homology (PH)
deficient NK cells compared to wild-type NK cells. NK domains that bind PtdIns (3,4,5)P3, it can be postulated
activity against YAC-1 cells is known to require the 2B4 that PI3K activity is necessary to generate binding sites
receptor, a member of the immunoglobulin receptor su- on the membrane at the receptor complex for one or
perfamily, and the receptor for CD48 (Brown et al., 1998). both of these enzymes.
As illustrated in Figure 6D, this activity was also de- The B cell defects also have considerable similarity
to those described in PKCb-deficient mice (Leitges etcreased in PLCg2-deficient NK cells.
Immunity
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Figure 4. Serum Immunoglobulin Levels and Serum Antibodies Response to TI and TD Antigens in PLCg2-Deficient Mice
(A) Serum immunoglobulin isotype levels in wild-type and PLCg2-deficient mice were determined by ELISA.
(B) Serum NP-specific immunoglobulin isotype response to TI-II antigen NP-Ficoll immunization in wild-type and PLCg2-deficient mice was
determined by ELISA.
(C) Serum OVA-specific immunoglobulin isotype response to TD antigen OVA/CFA immunization in wild-type and PLCg2-deficient mice was
determined by ELISA.
al., 1996). This suggests the possibility that activation platelets. Conversely, the functions of the Gaq-coupled
thrombin and ADP receptors were intact. On humanof PLCg2 is critical for the activation of PKCb and that
PKCb mediates the subsequent cellular responses. It platelets, the collagen binding protein glycoprotein VI
associates with the common Fc receptor g chain (FcRg),should be noted, however, that a role for PKCb in the
transphosphorylation or dephosphorylation of Btk has and GP VI is essential for platelet responses to collagen
as recently reviewed (Watson, 1999). Although not for-also been proposed (Leitges et al., 1996). In this context,
it is important to note ERK activation was not signifi- mally demonstrated, it is likely that GP VI functions com-
parably in mice. The FcRg chain contains immunorecep-cantly reduced by the absence of PLCg2.
The other striking phenotype of the PLCg2-deficient tor tyrosine±based activation motifs (ITAMs) that are
implicated in the recruitment of Syk to the complex.mice was the loss of function of the collagen receptor on
Roles of PLCg2
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Figure 5. Subcutaneous Hemorrhaging in PLCg2-Deficient Embryos and Adult Intestines Due to Platelet Defective Response to Collagen
(A) Morphology of 12-day-old wild-type and PLCg2-deficient embryos. The PLCg2-deficient embryo is characterized by the obvious diffuse
and subcutaneous hemorrhage.
(B) Morphology of intestines from adult wild-type and PLCg2-deficient mice.
(C) Histological appearance of intestines from adult wild-type and PLCg2-deficient mice.
(D) Release of thromboxane B2 (a stable breakdown product from thromboxane A2) from wild-type and PLCg2-deficient platelets in response
to collagen.
(E) Release of ATP from wild-type and PLCg2-deficient platelets in response to collagen. Collagen was added at the time indicated by arrow
a. Luciferin-luciferase were added at the time indicated by arrow b.
(F) Wild-type and PLCg2-deficient platelets aggregated in response to thrombin, ADP, and collagen.
Importantly, a deficiency in either the FcRg or Syk is demonstrated, PLCg2 deficiency is associated with an
inability of collagen to cause the release of either TXA2also accompanied by a loss of aggregation in response
to collagen, although the thrombin response is largely or ATP. These data and the observation that Gaq defi-
ciency is associated with the loss of collagen-inducedintact (Poole et al., 1997). Btk is also speculated to be
involved based on decreased platelet function in pa- aggregation (Offermanns et al., 1997) demonstrates that
the release of the mediators is the primary function oftients with mutations in Btk (Quek et al., 1998). More
recently, it has been shown that mice lacking SLP-76 collagen receptor/PLCg2 signal transduction.
The results further demonstrate that function of otheralso have bleeding defects associated with a loss of
collagen-induced platelet aggregation (Clements et al., Fc receptors are affected by the absence of PLCg2.
These include the IgE receptor on mast cells and the1999). Moreover, the absence of SLP-76 was associated
with the loss of induction of the tyrosine phosphorylation FcgRII/III and 2B4 receptors on NK cells. In contrast,
the phagocytic activity of macrophages against IgG-of PLCg2. A role for the membrane-associated adaptor
protein LAT in collagen receptor signaling and PLCg2 coated cells was not affected by the absence of PLCg2
(data not shown). Moreover, macrophage numbers andactivation has also been proposed (Pasquet et al., 1999).
Therefore, in platelets, it can be proposed that a com- differentiation were unaffected, although previous stud-
ies suggested that PLCg2 was necessary for macro-plex exists that consists of the FcRg, Syk, and the adap-
tor proteins SLP-76 and LAT. The function of this com- phage differentiation. The possibility exists that in mac-
rophages, PLCg1 may be functionally redundant toplex is, in part, to recruit and activate PLCg2. In addition,
recent studies have identified the Src kinases Fyn and PLCg2.
In considering the potential signaling complexes in BLyn in the complex, although whether they are essential
has not been established (Ezumi et al., 1998; Briddon cells and platelets that activate PLCg2, it is important
to also consider the complex in T cells that may beand Watson, 1999).
The function of PLCg2 in platelet activation could be involved in inducing a Ca21 signal. In the T cell receptor
complex, the adaptor proteins SLP-76 and LAT are es-envisioned to directly mediate platelet aggregation in
a manner comparable to that proposed for PLCb2/b3 sential for inducing a Ca21 flux by TCR engagement
(Pivniouk et al., 1998; Zhang et al., 1999). In addition,through the Gaq-coupled receptors (Offermanns et al.,
1997). Alternatively, PLCg2 may be required to mediate the Src kinases Lck and Fyn are critical in T cell receptor
signaling, as is the Syk homolog ZAP70. Moreover, thethe release of TXA2 and ATP/ADP, which activate G
protein±coupled receptors to activate PLCb2/b3. As Tec family kinases Itk and Rlk are redundantly required
Immunity
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Figure 6. Functional Characterization of FcRs on Wild-Type and PLCg2-Deficient Mast and NK Cells
(A) Mast cell serotonin release. Mast cells were preincubated with [3H]serotonin and monoclonal murine IgE. [3H]serotonin released into the
supernatant was quantitated after exposure to monoclonal anti-IgE.
(B) Mast cell IL-4 induction. Mast cells were preincubated with monoclonal murine IgE. IL-4 induction was measured by quantitative RT±PCR
after exposure to monoclonal anti-IgE.
(C) ADCC activities of splenic NK cells were tested on P815 cells coated with anti-FcgRII/III antibodies. Wild-type NK cells were incubated
with P815 cells coated (open squares) or uncoated (open diamonds) with anti-FcgRII/III antibodies. PLCg2-deficient NK cells were incubated
with P815 cells coated (closed diamonds) or uncoated (closed circles) with anti-FcgRII/III antibodies.
(D) Splenic NK cells were tested for lytic activity against the NK-sensitive target YAC-1. The open squares, shaded diamonds, and closed
circles represent wild-type, heterozygous, and PLCg2-deficient NK cells, respectively.
and 2 mM gancyclovir. ES clones were picked and expanded 7±10for T cell receptor signaling including IP3 generation and
days after electroporation. Correctly targeted and normal karyotypeCa21 mobilization (Schaeffer et al., 1999). Therefore, in
ES clones were injected into blastocyst as described (van DeursenT cells it can be proposed that the complex similarly
et al., 1993). Eight independent ES clones were injected, of which
contains Src kinases (Lck, Fyn), Tec family kinases (Itk, two gave germline transmission. The mice were maintained under
Rlk), ZAP70, and the adaptor proteins LAT and SLP-76, specific pathogen-free (SPF) conditions. Mouse tail DNA was pre-
pared as described (Hogan et al., 1994). Genotyping of mice wasall of which collaborate to recruit and activate PLCg1.
performed by Southern blot analysis or by PCR.The remarkable similarity of these complexes is consis-
tent with the evolution of a signaling complex from a
common progenitor that evolved within the context of Immunoprecipitation, SDS-PAGE, and Western Blotting
Immunoprecipitation, SDS-PAGE, and Western blotting were carriedthe family of immunoglobulin superfamily receptors.
out as previously described (Wang et al., 1996). The antibodies for
PLCg1, PLCg2, BTK, and BLNK were purchased from Santa Cruz.Experimental Procedures
Construction of PLCg2 Targeting Vector Colony Assays
With a 59 PLCg2 cDNA probe, the PLCg2 gene was isolated from a Cells were prepared from bone marrow in a-MEM medium (GIBCO±
129/SvE mouse genomic library in lEMBL3. For the PLCg2 targeting BRL) containing 2% fetal bovine serum (FBS) (StemCell Technolo-
vector, an 8 kb BamHI fragment was subcloned, followed by replace- gies) and counted in the presence of 3% acetic acid to lyse the
ment of a 3.8 kb XbaI fragment containing the second PLCg2 coding erythrocytes. The cells were plated and colonies were scored as
exon with a neomycin resistance cassette (van Deursen et al., 1991). previously described (Teglund et al., 1998).
A herpes simplex thymidine kinase (HSV-tk) cassette mediating neg-
ative selection was inserted in the 59-end of the PLCg2-neo con-
struct. Flow Cytometry and Calcium Fluorimetry
Thymus, spleen, and bone marrow cells obtained from wild-type or
mutant mice were made into single-cell suspensions in PBS supple-Generation of PLCg2-Deficient Mice
Conditions for E14 (129/Ola mouse strain) ES cell culture and elec- mented with 1% bovine serum albumin. The cells were then stained
with a cocktail of mAbs conjugated to fluorescein isothyocyanatetroporation of the NotI-linearized PLCg2 targeting construct into
the ES cells were performed as described. Selection 24 hr after (FITC), phycoerythrin (PE), or Cy-chrome. The stained cells were
analyzed in a Becton-Dickinson FACScan in three-color mode usingelectroporation was in 350 mg/ml geneticin (G418 [GIBCO±BRL])
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CellQuest software. FITC-conjugated anti-IgD, PE-conjugated anti- collected by centrifugation for 1 min at 16,000 g. Thromboxane A2
production was assessed by competitive enzyme immunoassay ofCD4, PE-conjugated anti-CD5, PE-conjugated anti-CD43, PE-conju-
gated anti-NK1.1, Cy-chrome-conjugated anti-CD8, and Cy-chrome- thromboxane B2 (a stable breakdown product of thromboxane A2)
(Cayman Chemicals, Ann Arbor, MI).conjugated anti-B220 were all purchased from PharMingen, San
Diego, CA. Both FITC- and PE-conjugated anti-IgM antibodies were For ATP release assay, the platelet-rich plasma (PRP) was stimu-
lated with collagen and stirred at 1000 rpm. At the end of the incuba-purchased from Southern Biotechnology, Birmingham, AL. Splenic
B cells were incubated with indo-1 (10 mg/ml, Molecular Probes) tion, 25 ml luciferin-luciferase (Chrono-lume reagent, Chrono-Log
Corporation) was added. Luminescence was recorded and the inten-and PE-conjugated anti-B220 antibody (PharMingen) at room tem-
perature for 30 min. Then cells were washed and stimulated with sity was expressed as an arbitrary unit.
an anti-IgM antibody. Calcium concentrations were determined in
B220-positive cells by flow cytometry. NK Cell Killing Assay
Single-cell suspensions of splenocytes from wild-type or mutant
Proliferation Assays mice were treated with Gey's solution to lyse red blood cells. The
B cells were purified as follows: single-cell suspensions of spleno- cells were then cultured at 5 3 106/ml in medium (NK medium)
cytes from wild-type or mutant mice were treated with Gey's solution consisting of RPMI 1640, 0.1 mM nonessential amino acids, 1 mM
to lyse red blood cells and were incubated in a culture flask at 378C sodium pyruvate, 5 3 1025 2-mercaptoethanol, 100 U/ml penicillin,
for 1 hr to purge the adherent macrophages. The nonadherent cells 100 mg/ml streptomycin, 2 mM glutamine, 1000 U/ml recombinant
were then incubated with an anti-Thy1.2 antibody (AT83), followed IL-2 (GIBCO±BRL), 1 mg/ml indomethacin (Sigma), and 10% heat-
by incubation with a mixture of rabbit and guinea pig complement inactivated FBS (HyClone). Fresh NK medium was added at a 1:1
(Cedarlane Laboratories) to lyse T cell population. Ninety percent volume after 3 days of culture. After a total of 5 days of culture, the
of the purified cells were positive for pan-B cell marker B220. The cells were harvested and used for 51Cr release assay.
resulting purified B cells were cultured at 5 3 105/well in round-
bottom 96-well plates in medium consisting of RPMI 1640, 0.1 mM Serotonin Release from Mast Cell
nonessential amino acids, 1 mM sodium pyruvate, 5 3 1025 M Bone marrow cells from wild-type or mutant mice were washed in
2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ml streptomycin, 2 PBS and cultured in mast cell medium consisting of RPMI 1640,
mM glutamine (all from GIBCO±BRL), and 10% heat-inactivated FBS 100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM glutamine, 25
(HyClone) with the following B cell mitogens: LPS (10 mg/ml, Sigma), U/ml recombinant IL-3, and 10% heat-inactivated FBS (HyClone);
anti-IgM (10 mg/ml, Jackson Laboratories) with or without IL-4 (40 the medium was replaced every 3±4 days. For serotonin release
ng/ml, R&D Systems), anti-CD40 (1 mg/ml, PharMingen), and PDBu assay, the bone marrow±derived mast cells were suspended at 1 3
(10 ng/ml, Sigma) plus inomycine (1 mg/ml, Sigma) for two days. 106/ml and incubated with mouse IgE MAb (4 mg/ml) and 5 mCi/ml
The culture was then pulsed with 1 mCi/well tritiated-deoxithymidine [3H]serotonin for 16 hr. The cells were extensively washed and then
(3H-dT, DuPont) for 18 hr and harvested. Incorporated 3H-dT was stimulated with anti-mouse IgE MAb (10 mg/ml) for 60 min. [3H]sero-
determined by a Betaplate Liquid Scintillation Counter. tonin released into the supernatant and remaining in the cell pellet
was quantitated.
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